BioCardia, Inc.
BCDA
$1.83
-$0.04-2.14%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | 3.00K | 58.00K | 71.00K | 428.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | 3.00K | 58.00K | 71.00K | 428.00K |
| Cost of Revenue | 2.27M | 1.70M | 1.42M | 4.13M | 5.07M |
| Gross Profit | -2.27M | -1.70M | -1.36M | -4.06M | -4.64M |
| SG&A Expenses | 3.61M | 3.78M | 3.67M | 3.71M | 3.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.85M | 8.46M | 8.06M | 7.84M | 9.03M |
| Operating Income | -8.85M | -8.45M | -8.00M | -7.76M | -8.61M |
| Income Before Tax | -8.79M | -8.39M | -7.95M | -7.72M | -8.56M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.79 | -8.39 | -7.95 | -7.72 | -8.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.79M | -8.39M | -7.95M | -7.72M | -8.56M |
| EBIT | -8.85M | -8.45M | -8.00M | -7.76M | -8.61M |
| EBITDA | -8.81M | -8.39M | -7.93M | -7.69M | -8.53M |
| EPS Basic | -2.10 | -2.58 | -3.34 | -4.22 | -5.40 |
| Normalized Basic EPS | -1.32 | -1.61 | -2.09 | -2.64 | -3.37 |
| EPS Diluted | -2.61 | -3.08 | -3.85 | -4.22 | -5.40 |
| Normalized Diluted EPS | -1.32 | -1.61 | -2.09 | -2.64 | -3.37 |
| Average Basic Shares Outstanding | 17.11M | 13.93M | 10.97M | 7.88M | 6.50M |
| Average Diluted Shares Outstanding | 17.11M | 13.93M | 10.97M | 7.88M | 6.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |